Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Preprints
, 2022, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in an Australian institution: Lessons from 20 years experience, http://dx.doi.org/10.21203/rs.3.rs-1773366/v1
, 2022, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in an Australian institution: Lessons from 20 years' experience, http://dx.doi.org/10.21203/rs.3.rs-1773366/v2
, Bromelain and acetylcysteine (BromAc®) alone and in combination with gemcitabine inhibit subcutaneous deposits of pancreatic cancer after intraperitoneal injection.
, Effect of Nebulised BromAc® on Mucus Plug in a Mechanically Ventilated Ex-Vivo Ovine Lung Model for Obstructive Respiratory Tract, http://dx.doi.org/10.20944/preprints202406.1231.v1
, Effect of nebulised BromAc® on rheology of artificial sputum: relevance to muco-obstructive respiratory diseases including COVID-19, http://dx.doi.org/10.1101/2021.12.28.474344
, Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19, http://dx.doi.org/10.1101/2021.12.23.21268347
, Novel technique and outcomes of umbilical reconstruction during cytoreductive surgery; a multi-centre study, http://dx.doi.org/10.21203/rs.3.rs-5135276/v1
, Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumors treated by cytoreductive surgery: Study protocol of a prospective, multi-center, observational study, http://dx.doi.org/10.1101/2021.04.01.21254760
, The combination of Bromelain and Acetylcysteine (BromAc) synergistically inactivates SARS-CoV-2, http://dx.doi.org/10.1101/2020.09.07.286906